Related Experiment Video

Updated: Jul 9, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

Kimberly Rose Blish1, Wei Wang, Mark C Willingham

  • 1Section on Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-0001, USA.

Molecular Biology of the Cell
|November 23, 2007
PubMed

Insights

SOSTDC1, a bone morphogenetic protein antagonist, is decreased in clear cell kidney cancer. Restoring SOSTDC1 suppresses cancer cell proliferation, suggesting it as a potential therapeutic target for kidney cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Nephrology

Background:

  • Kidney cancer is a significant health concern with diverse molecular subtypes.
  • Identifying novel biomarkers and therapeutic targets is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the expression of SOSTDC1 (sclerostin domain-containing-1) in normal kidney and kidney tumors.
  • To determine the functional role of SOSTDC1 in kidney cancer cell proliferation.

Main Methods:

  • Gene expression analysis using cDNA dot blots and immunohistochemistry.
  • Cellular assays including transfection and signaling pathway analysis (BMP-7 and Wnt-3a).

Main Results:

  • SOSTDC1 expression was significantly decreased in clear cell renal carcinomas compared to normal kidney tissue.
  • SOSTDC1 protein was abundant in specific normal kidney cell types (podocytes, distal tubules).
  • SOSTDC1 suppressed BMP and Wnt signaling pathways and inhibited proliferation of renal carcinoma cells.

Conclusions:

  • SOSTDC1 is downregulated in clear cell renal cell carcinoma.
  • SOSTDC1 exhibits tumor-suppressive properties by inhibiting proliferation.
  • Restoration of SOSTDC1 signaling represents a potential novel therapeutic strategy for kidney cancer.

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on: April 29, 2014

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...